As of 2026-01-06, the Relative Valuation of Arcus Biosciences Inc (RCUS) is (22.29) USD. This relative valuation is based on P/E multiples. With the latest stock price at 21.77 USD, the upside of Arcus Biosciences Inc based on Relative Valuation is -202.4%.
The range of the Relative Valuation is (9.29) - (35.06) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 3.7x - 14.0x | 8.8x |
| Forward P/E multiples | 3.7x - 14.3x | 9.0x |
| Fair Price | (9.29) - (35.06) | (22.29) |
| Upside | -142.7% - -261.0% | -202.4% |
| Date | P/E |
| 2025-12-23 | -9.09 |
| 2025-12-22 | -9.30 |
| 2025-12-19 | -8.80 |
| 2025-12-18 | -8.81 |
| 2025-12-17 | -8.92 |
| 2025-12-16 | -8.89 |
| 2025-12-15 | -8.77 |
| 2025-12-12 | -8.62 |
| 2025-12-11 | -10.07 |
| 2025-12-10 | -10.17 |
| 2025-12-09 | -10.04 |
| 2025-12-08 | -10.33 |
| 2025-12-05 | -10.19 |
| 2025-12-04 | -10.12 |
| 2025-12-03 | -10.26 |
| 2025-12-02 | -10.18 |
| 2025-12-01 | -10.45 |
| 2025-11-28 | -10.45 |
| 2025-11-26 | -10.24 |
| 2025-11-25 | -9.72 |
| 2025-11-24 | -9.28 |
| 2025-11-21 | -8.83 |
| 2025-11-20 | -8.50 |
| 2025-11-19 | -8.10 |
| 2025-11-18 | -8.09 |
| 2025-11-17 | -8.01 |
| 2025-11-14 | -8.04 |
| 2025-11-13 | -7.93 |
| 2025-11-12 | -8.01 |
| 2025-11-11 | -8.13 |
| 2025-11-10 | -7.79 |
| 2025-11-07 | -7.73 |
| 2025-11-06 | -7.83 |
| 2025-11-05 | -7.91 |
| 2025-11-04 | -7.94 |
| 2025-11-03 | -8.15 |
| 2025-10-31 | -7.90 |
| 2025-10-30 | -8.09 |
| 2025-10-29 | -8.13 |
| 2025-10-28 | -7.96 |
| 2025-10-27 | -7.45 |
| 2025-10-24 | -6.93 |
| 2025-10-23 | -6.72 |
| 2025-10-22 | -6.73 |
| 2025-10-21 | -7.23 |
| 2025-10-20 | -7.00 |
| 2025-10-17 | -6.60 |
| 2025-10-16 | -6.65 |
| 2025-10-15 | -6.77 |
| 2025-10-14 | -6.26 |